Trial intelligence / Profile preview

Huaren vs Baxter Peritoneal Dialysate in CAPD

NCT01779557Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Feb 2013
Primary completion
Oct 2019
Modality
Injectable Hydrogels
Countries
1
01

Overview

A Phase 4 trial of Huaren Peritoneal Dialysate in end stage renal disease (ESRD), sponsored by Chinese PLA General Hospital. Started Feb 2013; status: completed.

02

Drugs

Huaren Peritoneal Dialysate
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT01779557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01779557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call